The STREAM Trial (Prostatic Artery Embolization for the Treatment of Benign Prostatic Hyperplasia) 24-Month Clinical and Radiological Outcomes

Tapping, Charles R.; Little, Mark W.; Macdonald, Andrew; Tina, Mackinnon; Kearns, Daniel; Macpherson, Ruth E.; Crew, Jeremy; Boardman, Philip

doi:10.1007/s00270-020-02702-3

Cited by 11 publications

(6 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…IPSS questionnaire is an internationally used timing scoring system for the incidence of prostate symptoms and the degree of tolerance to current symptoms. Postoperative IPSS of the experimental group was lower than that of the control group, and the difference was statistically significant (P < 0.05), suggesting that the severity of prostatic hyperplasia symptoms was alleviated by cystostomy and transurethral four-zone division bipolar plasma partial prostatic enucleation [17]. As one of the important indicators to evaluate the therapeutic effect, quality of life (QOL) is paramount to evaluate the therapeutic effect of the treatment of chronic diseases.…”

Section: Discussionmentioning

confidence: 99%

Therapeutic Effect Analysis of Plasma Bipolar Intelligent Electrotonic for Cystostomy in the Treatment of Senile Prostatic Hyperplasia

You

Zhang

et al. 2021

Journal of Healthcare Engineering

View full text Add to dashboard Cite

To solve prostatic hyperplasia in the elderly, a method of cystostomy with plasma bipolar resection was proposed. From January 2019 to March 2020, 42 patients with BPH who needed surgical treatment in the urological department were selected. Cystostomy was performed in bipolar TURP. The cystostomy group and robot group were divided into two groups. The surgical safety, surgical efficiency, complications, and nursing time between the two groups were compared. The results showed that the experimental and control groups’ RUV values were significantly lower than those before surgery. In comparison, the Qmax value was considerably higher than that before surgery. The difference was statistically significant ( P < 0.05 ), suggesting that the cystostomy group in bipolar TURP had more substantial improvement of dysuria, better recovery of detrusor function, and better prognosis. It was proved that, for BPH below 80 g, cystostomy could reduce the operation time, bladder irrigation time, catheter indwelling time, and postoperative hospital stay, improve the operation efficiency, and have the same effect on patients’ symptoms improvement, more excellent psychological support, and higher quality of life score. It is proved that plasma bipolar resection combined with cystostomy can effectively improve annual BPH surgery.

show abstract

Section: Discussionmentioning

confidence: 99%

Therapeutic Effect Analysis of Plasma Bipolar Intelligent Electrotonic for Cystostomy in the Treatment of Senile Prostatic Hyperplasia

You

Zhang

et al. 2021

Journal of Healthcare Engineering

View full text Add to dashboard Cite

show abstract

“…Although prostate MRI is not routinely obtained before BPH interventions in clinical practice, a small number of investigations have explored the role of preprocedural MRI for predicting outcomes of BPH interventions. In one study, a longitudinal (craniocaudal greater than transverse dimension) rather than oval shape (transverse greater than craniocaudal dimension) of the prostate on MRI was associated with improved procedural efficiency but no difference in patient outcomes after holmium laser enucleation of the prostate (HoLEP) [24] In an additional study, adenomatous BPH on MRI was associated with better outcomes at 12 months (but not 24 months) after prostate artery embolization (PAE) [25]. Further, in an age-matched case control study with a total of 24 patients, patients with hypervascularized adenomatous-dominant BPH on MRI responded better to PAE versus those with non-adenomatous-dominant BPH [26].…”

Section: Accepted Manuscriptmentioning

confidence: 99%

“…MLH, depicted on sagittal T2WI as intravesical prostatic protrusion, is thought to cause LUTS in some patients via a ball-valve mechanism [17,22]. However, presence of MLH does not affect outcomes after photoselective vaporization of the prostate (PVP) [27], Rezum [28], or PAE [25].…”

Section: Accepted Manuscriptmentioning

confidence: 99%

MRI Evaluation of Patients Before and After Interventions for Benign Prostatic Hyperplasia: An Update

Diaz

Benson

Clinkenbeard

et al. 2022

American Journal of Roentgenology

View full text Add to dashboard Cite

The publication of this Accepted Manuscript is provided to give early visibility to the contents of the article, which will undergo additional copyediting, typesetting, and review before it is published in its final form. During the production process, errors may be discovered that could affect the content of the Accepted Manuscript. All legal disclaimers that apply to the journal pertain. The reader is cautioned to consult the definitive version of record before relying on the contents of this document.

show abstract

“…5 PAE appears to alleviate both static and dynamic components of BPE, although the exact mechanism and extent for each is still under investigation. 6,7 Several prospective studies have demonstrated short to mid-term safety and efficacy of PAE across gland sizes. 8,9 Recently, two of the most experienced groups have published their 10-year experience with PAE, demonstrating long-term safety and efficacy.…”

Section: Prostate Artery Embolization For Treatment Of Lower Urinary ...mentioning

confidence: 99%

Controversies in Prostate Artery Embolization: Future Best Practice

Goyal

Salem

Mouli

2022

Semin intervent Radiol

View full text Add to dashboard Cite

Prevalence of lower urinary tract symptoms secondary to benign prostatic hyperplasia is correlated with age. Men seeking treatment options with a low side effect profile often turn to prostate artery embolization (PAE). PAE continues to be refined with advanced tools and optimized techniques. Nonetheless, there exist controversies in terms of best practices for the management of lower urinary track symptoms (LUTS) with PAE. These controversies are essential for medical progress. Herein we suggest best practices moving forward based on currently available data. Given extensive safety data, we recommend PAE be considered alongside medical management and as a precursor to surgery. Given demonstrated efficacy across gland sizes, PAE can be performed in a single session, ideally in a hybrid angio-CT suite, without preoperative cross-sectional imaging. PAE should be initially performed with 300- to 500-μm size particles, and instead consider exploring other particles and sizes for repeat PAE. Finally, PAE can also be considered as first-line option for recurrent disease given the efficacy and excellent safety profile. This article is not meant to purport a dogma, but rather to serve as a guide to the experienced practitioner in challenging his or her own biases when performing PAE.

show abstract

The STREAM Trial (Prostatic Artery Embolization for the Treatment of Benign Prostatic Hyperplasia) 24-Month Clinical and Radiological Outcomes

Cited by 11 publications

References 9 publications

Therapeutic Effect Analysis of Plasma Bipolar Intelligent Electrotonic for Cystostomy in the Treatment of Senile Prostatic Hyperplasia

Therapeutic Effect Analysis of Plasma Bipolar Intelligent Electrotonic for Cystostomy in the Treatment of Senile Prostatic Hyperplasia

MRI Evaluation of Patients Before and After Interventions for Benign Prostatic Hyperplasia: An Update

Controversies in Prostate Artery Embolization: Future Best Practice

Contact Info

Product

Resources

About